Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar 7;201(5):723-35.
doi: 10.1084/jem.20041982.

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

Ruka Setoguchi  1 , Shohei Hori, Takeshi Takahashi, Shimon Sakaguchi
Affiliations

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

Ruka Setoguchi et al. J Exp Med. .

Abstract

Interleukin (IL)-2 plays a crucial role in the maintenance of natural immunologic self-tolerance. Neutralization of circulating IL-2 by anti-IL-2 monoclonal antibody for a limited period elicits autoimmune gastritis in BALB/c mice. Similar treatment of diabetes-prone nonobese diabetic mice triggers early onset of diabetes and produces a wide spectrum of T cell-mediated autoimmune diseases, including gastritis, thyroiditis, sialadenitis, and notably, severe neuropathy. Such treatment selectively reduces the number of Foxp3-expressing CD25(+) CD4(+) T cells, but not CD25(-) CD4(+) T cells, in the thymus and periphery of normal and thymectomized mice. IL-2 neutralization inhibits physiological proliferation of peripheral CD25(+) CD4(+) T cells that are presumably responding to normal self-antigens, whereas it is unable to inhibit their lymphopenia-induced homeostatic expansion in a T cell-deficient environment. In normal naive mice, CD25(low) CD4(+) nonregulatory T cells actively transcribe the IL-2 gene and secrete IL-2 protein in the physiological state. IL-2 is thus indispensable for the peripheral maintenance of natural CD25(+) CD4(+) regulatory T cells (T reg cells). The principal physiological source of IL-2 for the maintenance of T reg cells appears to be other T cells, especially CD25(low) CD4(+) activated T cells, which include self-reactive T cells. Furthermore, impairment of this negative feedback loop via IL-2 can be a cause and a predisposing factor for autoimmune disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Neutralization of IL-2 by specific mAbs reduces the number of Foxp3 + CD25+ CD4+ T reg cells in normal naive mice. (A) Expression of CD122 (IL-2Rβ) and CD132 (IL-2Rγc) by CD25+ or CD25− CD4+ T cells in the thymus or spleen of normal BALB/c mice. Dotted lines represent control staining with isotype-matched mAb. (B) Representative flow cytometric profiles of thymus and spleen cells from 8-wk-old BALB/c mice 14 d after injection of anti–IL-2 mAb or saline. Kinetics of the number of CD25+ CD4+ T cells and CD25− CD4+ T cells after injection of anti–IL-2 mAb (black circles) or saline (white circles). Asterisks indicate significant differences (P < 0.05). (C) Relative Foxp3 mRNA levels assessed by real-time quantitative PCR with CD4+ CD8− thymocytes or CD4+ splenocytes from mice treated with anti–IL-2 mAbs. Quantity of Foxp3 normalized to HPRT. (D) BALB/c nude mice were i.v. transferred with spleen cells (3 × 107) from BALB/c mice injected with anti–IL-2 mAbs or saline 14 d earlier with or without CD25+ CD4+ T cells (106) from nonmanipulated mice and examined histologically and serologically 3 mo later. Titers of anti-parietal cell autoantibodies were assessed by ELISA. Black circles, macroscopically and histologically evident grade 2 gastritis; gray circles, histologically evident grade 1 gastritis; white circles, intact gastritis mucosa. See reference for histological grading.
Figure 2.
Figure 2.
IL-2 neutralization decreases the number of CD25+ CD4+ T cells in Tx mice. Adult BALB/c mice were Tx (Tx, +) or sham operated (Tx, −). 3 wk later, animals were injected with anti–IL-2 mAb or saline and the percentages of CD25+ CD4+ T cells among the CD4+ T cells (A) and their absolute numbers (B) were determined on day 14 after antibody injection.
Figure 3.
Figure 3.
Neutralization of IL-2 inhibits natural in vivo proliferation of peripheral CD25+ CD4+ T cells in normal mice. BALB/c mice received one injection of 1 mg anti–IL-2 mAb or saline and were treated with BrdU for the next 3 d. Percentage of BrdU-labeled CD25+ or CD25− CD4+ T cells from anti–IL-2–treated mice or saline-treated mice was assessed by flow cytometry using FITC-labeled anti-BrdU mAb. (A) Representative flow cytometric profiles. (B) Percent of BrdU+ cells among CD25+ or CD25− CD4+ T cells in mice treated with anti–IL-2 mAb or saline. NS, not significant.
Figure 4.
Figure 4.
IL-2–independent lymphopenia-driven expansion of CD25+ CD4+ T cells. (A) CD25+ CD4+ T cells (3 × 105) purified from Thy-1.1 BALB/c mice were labeled with CFSE and injected into RAG-2−/− mice that were treated with anti–IL-2 mAb or control rat IgG and assessed for the percentage of CFSE-labeled cells 4 d later. (B) CD25+ CD4+ T cells (3 × 105) highly purified from BALB/c-Thy1.1 mice were transferred to BALB/c IL-2+/+ or IL-2−/− BALB/c RAG-2−/− mice. A group of IL-2−/− RAG-2−/− BALB/c mice transferred with CD25+ CD4+ T cells were treated with anti–IL-2 mAb. Another group of IL-2−/− RAG-2−/− BALB/c mice received a cotransfer of an equal number (3 × 105) of CD25+ CD4+ T cells and CD25− CD4+ T cells sorted from the lymph nodes of normal BALB/c mice. The numbers of Thy1.1+ TCRβ+ cells recovered in the spleen of individual recipients were assessed 4 wk after transfer.
Figure 5.
Figure 5.
Active transcription of the IL-2 gene in CD25low CD4+ nonregulatory T cells in the spleens of normal BALB/c mice. (A) Splenic CD4+ T cells were sorted into CD25high, CD25low, and CD25− subpopulations as shown and compared with other cell populations in the spleen (see Results) for expression levels of IL-2 mRNA assessed by real-time quantitative RT-PCR (normalized to HPRT). The average IL-2 mRNA levels of total unseparated spleen cells was defined to be 1. The level of IL-2 mRNA in in vitro–activated CD25− CD4+ T cells (stimulated for 24 h with precoated 1 μg/ml anti-CD3 and 1 μg/ml of soluble anti-CD28) was 1,000–1,500 (not depicted). Sorted CD25high, CD25low, and CD25− CD4+ T cells were cultured for 24 h, and the IL-2 concentrations in the supernatant were determined by ELISA. The results of three independent experiments are shown. (B) CD25high, CD25low, and CD25− CD4+ populations from DO11.10 TCR transgenic mice (DO.RAG+) or the CD25− CD4+ population from RAG−/− DO11.10 transgenic mice (DO.RAG−) were assessed for the expression of IL-2 mRNA by real-time PCR and for the expression of transgenic TCR by FACS analysis using the clonotypic KJ1-26 mAb. (C) Relative Foxp3 mRNA levels in CD25high, CD25low, or CD25− CD4+ T cells from the spleens of DO.RAG+, DO.RAG−, or normal BALB/c mice. (D) In vitro responsiveness and suppressive activity of splenic CD25high or CD25low CD4+ T cells from normal BALB/c mice. These populations were stimulated for 3 d with anti-CD3 mAb and APC either alone or in the presence of an equal number of CD25− CD4+ responder T cells, and [3H]thymidine incorporation was measured. A representative of three independent experiments is shown in A–D. N.D., none detected.
Figure 6.
Figure 6.
Induction of autoimmune gastritis in BALB/c mice by IL-2 neutralization. BALB/c mice were i.p. injected with 1 mg purified anti–IL-2 mAb or saline on days 10 and 20 after birth and were examined at 3 mo of age for histological and serological evidence for gastritis. (A) Hematoxylin and eosin staining of gastric mucosa of anti–IL-2–treated and saline-treated mice (a magnification of 20). (B) Titers of anti-parietal cell autoantibodies were determined by ELISA. The gastric lesion was histologically graded as described in Fig. 1 D. (C) 3 × 107 spleen cells from anti–IL-2–treated mice showing gastritis or from saline-treated control mice were i.v. transferred to BALB/c athymic nude mice, which were histologically and serologically examined 3 mo later. Gastritis was scored as in Fig. 1 D.
Figure 7.
Figure 7.
Exacerbation of diabetes and induction of other organ-specific autoimmune diseases in NOD mice by IL-2 neutralization. Female NOD mice were injected i.p. with 1 mg of purified anti–IL-2 mAbs (n = 16) or rat IgG (n = 16) on days 10 and 20 after birth. Their blood glucose levels were measured every week starting from 7 wk of age. (A) Incidence of diabetes. (B) Hematoxylin and eosin staining of pancreas, thyroid, and lachrymal glands (a magnification of 5–10). (C) Severity of insulitis. Grade 1, peri-insulitis; grade 2, moderate insulitis; grade 3, severe insulitis (reference 59). (D and E) Titers of anti-parietal cell autoantibodies (D) and anti-thyroglobulin autoantibodies (E) in the sera of anti–IL-2–treated mice (n = 11) and rat IgG-treated mice (n = 12) assessed by ELISA.
Figure 8.
Figure 8.
Spontaneous development of autoimmune neuropathy in NOD mice treated with anti–IL-2 mAb. Female NOD mice treated as shown in Fig. 7 were checked weekly for clinical signs of neuropathy (hind and front leg paralysis). (A) Incidence of macroscopically evident neuropathy. (B) A mouse with paralysis of hind limbs. (C) Hematoxylin and eosin staining of the sections of the peripheral nerves (left; a magnification of 20) and sciatic nerves (middle; a magnification of 40). Luxol fast blue staining of peripheral nerves (right; a magnification of 40). (D) A NOD.SCID mouse showing paralysis of hind legs after receiving CD4+ T cells from anti–IL-2–treated NOD mice with neuropathy (left). Hematoxylin and eosin staining of sciatic nerve from the NOD.SCID mouse (right; a magnification of 40). (E) Spleen cells from NOD mice with neuropathy were sorted to CD4+ and CD4− cells by MACS, and 4–6 × 106 cells of each population were transferred to NOD.SCID mice. Grade 1, lymphocytic infiltration in the peripheral nerves without clinical signs; grade 2, clinical signs of neuropathy with lymphocytic infiltration in peripheral nerves.
Figure 9.
Figure 9.
Development of various autoimmune diseases in NOD mice after anti–IL-2 treatment. Individual NOD female mice that were treated as shown in Fig. 7 and individual mice that survived to 20 wk of age (11 anti–IL-2–treated mice and 12 control mice) were assessed clinically and histologically. DM, diabetes mellitus; NP, neuropathy; Neur, neuritis; Ins, insulitis; Gas, gastritis; Thyr, thyroiditis; Sial, sialadenitis; lacr, lacrimal gland adenitis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Horak, I., J. Lohler, A. Ma, and K.A. Smith. 1995. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148:35–44. - PubMed
    1. Kramer, S., A. Schimpl, and T. Hunig. 1995. Immunopathology of interleukin (IL)-2–deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182:1769–1776. - PMC - PubMed
    1. Serreze, D.V., K. Hamaguchi, and E.H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759–776. - PubMed
    1. Zielasek, J., V. Burkart, P. Naylor, A. Goldstein, U. Kiesel, and H. Kolb. 1990. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats. Immunology. 69:209–214. - PMC - PubMed
    1. Gutierrez-Ramos, J.C., J.L. Andreu, Y. Revilla, E. Vinuela, and C. Martinez. 1990. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature. 346:271–274. - PubMed

Publication types

MeSH terms